Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosys, officially Biochemical Systems International, is an Italian medical device and diagnostics company focused on rapid diagnostics, telemedicine, and clinical chemistry analysis. The company develops, manufactures, and commercializes point-of-care and home-use diagnostic devices, with particular emphasis on blood glucose monitoring and connected metabolic monitoring solutions. Its product portfolio appears to include branded systems such as Aria, V-TRUST, OGCare, and MulticareIN, and the company also highlights internal R&D, quality control, technical support, logistics, and manufacturing capabilities in Tuscany. Biosys serves healthcare providers, hospitals, and home-care settings rather than operating as a therapeutics developer. For a biotech or medtech analyst, this is best characterized as a commercial-stage private Italian diagnostics and medical technology business centered on IVD devices and telemedicine-enabled patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosys.